Cross-sectional study of potential incompatibility of intravenous medications in a neonatal intensive care unit in Indonesia
Farmacia Hospitalaria · 2023
DOI: 10.1016/j.farma.2022.11.007 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Farmacia Hospitalaria, 2023. Verfasst von Andika Dwi Mahendra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, dr Soeradji Tirtonegoro General Hospital, Indonesian Islamic University, Klaten 57424, Indonesia; Department of Pharmacy, Fac…. Hauptthemen laut MEDLINE: Intensive Care Units, Neonatal, Amikacin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universitas Islam Indonesia.
Themen: Neonatologie, Intensivpflege
Abstract (Originalsprache)
OBJECTIVE: The purpose of this study is to determine the most common incompatible and unknown compatibility drug combinations and determine the compatibility of each pair of drugs used in hospitals based on reference books and journals. METHODS: This is a prospective cross sectional study. All babies who were admitted to the Neonatal Intensive Care Units from May 1 to July 31 2021 were sample of the study. Patients who did not receive at least two drug coadministrated concurrently and who stayed less than 24 hours were excluded. Only drug-drug combinations were considered and the other non-drug administrations (electrolyte solutions, parenteral nutritions, and blood products) were excluded. Compatibility data were obtained from literature and online search engines [micromedex NeoFax Essentials 2020, UCL Hospitals Injectable Medicines Administration Guide: Pharmacy Department, 3rd Edition, Trissel Handbook on injectable drugs 15th edition, and published journals]. RESULTS: The most commonly prescribed drug combinations were ampicillin-gentamicin (31.72%), amikacin-ampicillin sulbactam (9.05%), amikacin-ampicillin sulbactam-aminophylline (3.08%). The most common drug incompatible combination was ampicillin - gentamicin (31.71%), for the most drug combinations whose compatibility unknown were amikacin-ampicillin sulbactam (9.05%). CONCLUSION: The high prevalence of incompatible drugs and unknown compatibility was identified, so checking its compatibility can be carried out through a two-dimensional chart to minimize the incidence of incompatibilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, dr Soeradji Tirtonegoro General Hospital, Indonesian Islamic University, Klaten 57424, Indonesia; Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Islam Indonesia,…
- Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Islam Indonesia, Yogyakarta 55584, Indonesia.
Förderung
- Universitas Islam Indonesia
Zitieren
APA
Mahendra, A. D., Hanifah, S., & Sari, C. P. (2023). Cross-sectional study of potential incompatibility of intravenous medications in a neonatal intensive care unit in Indonesia. Farmacia Hospitalaria. https://doi.org/10.1016/j.farma.2022.11.007
Vancouver
Mahendra AD, Hanifah S, Sari CP. Cross-sectional study of potential incompatibility of intravenous medications in a neonatal intensive care unit in Indonesia. Farmacia Hospitalaria. 2023. doi:10.1016/j.farma.2022.11.007
BibTeX
@article{Mahendra2023,
author = {Mahendra, Andika Dwi and Hanifah, Suci and Sari, Chynthia Pradiftha},
title = {Cross-sectional study of potential incompatibility of intravenous medications in a neonatal intensive care unit in Indonesia},
journal = {Farmacia Hospitalaria},
year = {2023},
doi = {10.1016/j.farma.2022.11.007}
}
EUVIMED